Skip to main content

Advertisement

SpringerLink
Log in

In vivo single molecular imaging and sentinel node navigation by nanotechnology for molecular targeting drug-delivery systems and tailor-made medicine

  • Conference Paper
  • Presidential symposium: Individualized diagnosis for tailored treatment of breast cancer
  • Published:
Breast Cancer Aims and scope Submit manuscript

Abstract

The recent advances in nanotechnology have a great potential to improve the prevention, diagnosis, and treatment of human diseases. Nanomaterials for medical applications are expected to grasp pharmacokinetics and the toxicity for application to medical treatment on the aspect of safety of the nanomaterials and nanodevices. We describe a generation of CdSe nanoparticles [quantum dots (QDs)] conjugated with monoclonal anti-HER2 antibody (Trastuzumab), for single molecular in vivo imaging of breast cancer cells. We established a high-resolution in vivo 3D microscopic system for a novel imaging method at the molecular level. The cancer cells expressing HER2 protein were visualized by the nanoparticles in vivo at subcellular resolution, suggesting future utilization of the system in medical applications to improve drug-delivery systems to target the primary and metastatic tumors for made-to-order treatment. We also describe sentinel node navigation using fluorescent nanoparticles for breast cancer surgery in experimental model, which have shown the potential to be an alternative to existing tracers in the detection of the sentinel node if we select the appropriate particle size and wavelength. Future innovation in cancer imaging by nanotechnology and novel measurement technology will provide great improvement, not only in the clinical field but also in basic medical science for the development of medicine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Torchilin VP, Lukyanov AN, Gao Z, Papahadjopoulos-Sternberg B. Immunomicelles: targeted pharmaceutical carriers for poorly soluble drugs. Proc Natl Acad Sci USA. 2003;100:6039–44.

    Article  PubMed  CAS  Google Scholar 

  2. Krauss WC, Park JW, Kirpotin DB, Hong K, Benz CC. Emerging antibody-based HER2 (ErbB-2/neu) therapeutics. Breast Dis. 2000;11:113–24.

    PubMed  CAS  Google Scholar 

  3. Lyons SK. Advances in imaging mouse tumour models in vivo. J Pathol. 2005;205:194–205.

    Article  PubMed  CAS  Google Scholar 

  4. Ishijima A, Kojima H, Funatsu T, Tokunaga M, Higuchi H, Tanaka H. Simultaneous observation of individual ATPase, mechanical events by a single myosin molecule during interaction with actin. Cell. 1998;92:161–71.

    Article  PubMed  CAS  Google Scholar 

  5. Wu X, Liu H, Liu J, Haley KN, Treadway JA, Larson JP. Immunofluorescent labeling of cancer marker Her2, other cellular targets with semiconductor quantum dots. Nat Biotechnol. 2003;21:41–6.

    Article  PubMed  CAS  Google Scholar 

  6. Gao X, Cui Y, Levenson RM, Chung LW, Nie S. In vivo cancer targeting, imaging with semiconductor quantum dots. Nat Biotechnol. 2004;22:969–76.

    Article  PubMed  CAS  Google Scholar 

  7. Yildiz A, Forkey JN, McKinney SA, Ha T, Goldman YE, Selvin PR. Myosin V walks hand-over-hand: single fluorophore imaging with 1.5-nm localization. Science. 2003;300:2061–5.

    Article  PubMed  CAS  Google Scholar 

  8. Dahan M, Levi S, Luccardini C, Rostaing P, Riveau B, Triller A. Diffusion dynamics of glycine receptors revealed by single-quantum dot tracking. Science. 2003;302:442–5.

    Article  PubMed  CAS  Google Scholar 

  9. Lidke DS, Nagy P, Heintzmann R, Arndt-Jovin DJ, Post JN, Grecco HE, Jares-Erijman EA, Jovin TM. Quantum dot ligands provide new insights into erbB/HER receptor-mediated signal transduction. Nat Biotechnol. 2004;22:198–203.

    Article  PubMed  CAS  Google Scholar 

  10. Krag DN, Weaver DL, Alex JC. Surgical resection and radio-localization of the sentinel node in breast cancer using a gamma probe. Surg Oncol. 1993;2:335–40.

    Article  PubMed  CAS  Google Scholar 

  11. Tafra L, Lannin DR, Swanson MS. Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye. Ann Surg. 2001;233:51–9.

    Article  PubMed  CAS  Google Scholar 

  12. Kurebayashi J, Otsuki T, Tang CK, Kurosumi M, Yamamoto S, Tanaka K, Mochizuki M, Nakamura H, Sonoo H. Isolation and characterization of a new human breast cancer cell line, KPL-4, expressing the Erb B family receptors and interleukin-6. Br J Cancer. 1999;79:707–17.

    Article  PubMed  CAS  Google Scholar 

  13. Leunig M, Yuan F, Menger MD, Boucher Y, Goetz AE, Messmer K, Jain RK. Angiogenesis, microvascular architecture, microhemodynamics, and interstitial fluid pressure during early growth of human adenocarcinoma LS174T in SCID mice. Cancer Res. 1992;52:6553–60.

    PubMed  CAS  Google Scholar 

  14. Braun RD, Abbas A, Bukhari SO, Wilson W III. Hemodynamic parameters in blood vessels in choroidal melanoma xenografts and rat choroid. Invest Ophthalmol Vis Sci. 2002;43:3045–52.

    PubMed  Google Scholar 

  15. Carraway CA, Carvajal ME, Carraway KL. Association of the Ras to mitogen-activated protein kinase signal transduction pathway with microfilaments. Evidence for a p185 (neu)-containing cell surface signal transduction particle linking the mitogenic pathway to a membrane-microfilament association site. J Biol Chem. 1999;274:25659–67.

    Article  PubMed  CAS  Google Scholar 

  16. Buss F, Arden SD, Lindsay M, Luzio JP, Kendrick-Jones J. Myosin VI isoform localized to clathrin-coated vesicles with a role in clathrin-mediated endocytosis. EMBO J. 2001;20:3676–84.

    Article  PubMed  CAS  Google Scholar 

  17. Kamal A, Goldstein LS. Connecting vesicle transport to the cytoskeleton. Curr Opin Cell Biol. 2000;12:503–8.

    Article  PubMed  CAS  Google Scholar 

  18. Mross K, Niemann B, Massing U, Drevs J, Unger C, Bhamra R, Swenson CE. Pharmacokinetics of liposomal doxorubicin (TLC-D99; Myocet) in patients with solid tumors: an open-label, single-dose study. Cancer Chemother Pharmacol. 2004;54:514–24.

    Article  PubMed  CAS  Google Scholar 

  19. O’Brien ME, Wigler N, Inbar M, Rosso R, Grischke E, Santoro A. Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer. Ann Oncol. 2004;15:440–9.

    Article  PubMed  CAS  Google Scholar 

  20. Hamaguchi T, Matsumura Y, Nakanishi Y, Muro K, Yamada Y, Shimada Y. Antitumor effect of MCC-465, pegylated liposomal doxorubicin tagged with newly developed monoclonal antibody GAH, in colorectal cancer xenografts. Cancer Sci. 2004;95:608–13.

    Article  PubMed  CAS  Google Scholar 

  21. Park JW, Kirpotin DB, Hong K, Shalaby R, Shao Y, Nielsen UB. Tumor targeting using anti-her2 immunoliposomes. J Control Release. 2001;74:95–113.

    Article  PubMed  CAS  Google Scholar 

  22. Josephson L, Mahmood U, Wunderbaldinger P, Tang Y, Weissleder R. Pan and sentinel lymph node visualization using a near-infrared fluorescent probe. Mol Imaging. 2003;2:18–23.

    Article  PubMed  Google Scholar 

  23. Patrick W, Karl T, Chrstoph B. Near-infrared fluorescence imaging of lymph nodes using a new enzyme sensing activatable macromolecular optical probe. Eur Radiol. 2003;13:2206–11.

    Article  Google Scholar 

  24. Kobayashi M, Mizumoto T, Shibuya Y, Takeda M, Enomoto M. Fluorescence tomography in turbid media based on acousto-optic modulation imaging. Appl Phys Lett. 2006;89:181102.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgical Oncology, Graduate School of Medicine, Tohoku University, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan

    Motohiro Takeda, Hiroshi Tada, Yuu Sakurai, Takanori Ishida & Noriaki Ohuchi

  2. Department of Bioengineering and Robotics, Graduate School of Engineering, Tohoku University, Aoba 01, Sendai, 980-8579, Japan

    Motohiro Takeda

  3. Biomedical Engineering Research Organization, Tohoku University, Sendai, 6-6-11-901, Aramaki, Aoba-ku, Sendai, 980-8579, Japan

    Hideo Higuchi

  4. Department of Biomolecular Functional Engineering, College of Engineering, Ibaraki University, 4-12-1 Naka-narusawa-cho, Hitachi, Ibaraki, 316-8511, Japan

    Yoshio Kobayashi

  5. Division of Electronics, Tohoku Institute of Technology, 35-1 Kasumi-cho, Yagiyama, Taihaku-ku, Sendai, 982-8577, Japan

    Masaki Kobayashi

Authors
  1. Motohiro Takeda
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hiroshi Tada
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hideo Higuchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yoshio Kobayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Masaki Kobayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yuu Sakurai
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Takanori Ishida
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Noriaki Ohuchi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Motohiro Takeda.

Additional information

This article is based on a presentation delivered at the Presidential Symposium 1, “Breast cancer: individualized diagnosis for tailored treatment,” held on 29 June 2007 at the 15th Annual Meeting of the Japanese Breast Cancer Society in Yokohama.

About this article

Cite this article

Takeda, M., Tada, H., Higuchi, H. et al. In vivo single molecular imaging and sentinel node navigation by nanotechnology for molecular targeting drug-delivery systems and tailor-made medicine. Breast Cancer 15, 145–152 (2008). https://doi.org/10.1007/s12282-008-0037-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12282-008-0037-0

Keywords

Search

Navigation